Loring Wolcott & Coolidge Fiduciary Advisors’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2
Closed -$11 608
2023
Q2
$11 Hold
2
﹤0.01% 631
2023
Q1
$15 Hold
2
﹤0.01% 594
2022
Q4
$19 Hold
2
﹤0.01% 574
2022
Q3
$0 Hold
2
﹤0.01% 598
2022
Q2
$0 Hold
2
﹤0.01% 626
2022
Q1
$0 Hold
2
﹤0.01% 632
2021
Q4
$0 Hold
2
﹤0.01% 718
2021
Q3
$0 Hold
2
﹤0.01% 747
2021
Q2
$0 Buy
+2
New +$173 ﹤0.01% 943
2021
Q1
Sell
-2
Closed 302
2020
Q4
$0 Hold
2
﹤0.01% 765
2020
Q3
$0 Hold
2
﹤0.01% 586
2020
Q2
$0 Hold
2
﹤0.01% 583
2020
Q1
$0 Buy
+2
New +$357 ﹤0.01% 646

Other funds holding ACB

Loring Wolcott & Coolidge Fiduciary Advisors's ACB Position: Q3 2023 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Aurora Cannabis (ACB) in Q3 2023, closing a stake of 2 shares — an estimated $11 sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in ACB in Q1 2020 and held it in 13 quarters. The position peaked at $19 in Q4 2022. 201 funds tracked by Wall St. Rank hold ACB as of Q3 2023.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Aurora Cannabis position as of Q3 2023 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 2 Aurora Cannabis shares in Q3 2023, an estimated $11.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Aurora Cannabis in Q1 2020 and held it in 13 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Aurora Cannabis position peaked at $19 in Q4 2022.
  • 201 funds tracked by Wall St. Rank held Aurora Cannabis as of Q3 2023.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q3 2023, filed 3 Nov 2023.